Novel analogues of 3-substituted-2,3-dihydro-1,4-dioxino[2,3-b]pyridines: Modifications in the dioxane ring

Tetrahedron Letters

Volumn 44, Issue 47, 2003, Pages 8545-8548

  Bartoloméa, José M ^a   Alcázar, Jesús ^a   Andrés, J Ignacio ^a   De Bruyn, Marcel ^b   Fernández, Javier ^a   Matesanz, Encarna ^a   Van Emelen, Kristof ^b  

^a Jarama S/n 45007 Toledo Spain   (Spain)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 1,4 DIOXINO[2,3 B]PYRIDINE; DIOXANE; METHYL GROUP; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS;

EID: 0142169039     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2003.09.145     Document Type: Article

References (28)

1. For recent reports involving 2,3-dihydro-1,4-benzodioxin derivatives, see: (a) Czompa, A.; Dinya, Z.; Antus, S.; Varga, Z. Arch. Pharm. 2000, 333, 175-180; (b) Gu, W. X.; Jing, X. B.; Pan, X. F.; Chan, A. S. C.; Yang, T. K. Tetrahedron Lett. 2000, 41, 6079-6082; (c) Ward, R. S. Nat. Prod. Rep. 1999, 16, 75-96; (d) Bolognesi, M. L.; Budriesi, R.; Cavalli, A.; Chiarini, A.; Gotti, R.; Leonardi, A.; Minarini, A.; Poggesi, E.; Recanatini, M.; Rosini, M.; Tumiatti, V.; Melchiorre, C. J. Med. Chem. 1999, 42, 4214-4224; (d) Guillaumet, G. In Comprehensive Heterocyclic Chemistry II, 1st ed.; Katrizky, A. R.; Rees, C. W.; Scriven, E. F. V., Eds.; Pergamon: Oxford, 1996; Vol. 6, pp. 447-463.
2. For recent reports involving 2,3-dihydro-1,4-benzodioxin derivatives, see: (a) Czompa, A.; Dinya, Z.; Antus, S.; Varga, Z. Arch. Pharm. 2000, 333, 175-180; (b) Gu, W. X.; Jing, X. B.; Pan, X. F.; Chan, A. S. C.; Yang, T. K. Tetrahedron Lett. 2000, 41, 6079-6082; (c) Ward, R. S. Nat. Prod. Rep. 1999, 16, 75-96; (d) Bolognesi, M. L.; Budriesi, R.; Cavalli, A.; Chiarini, A.; Gotti, R.; Leonardi, A.; Minarini, A.; Poggesi, E.; Recanatini, M.; Rosini, M.; Tumiatti, V.; Melchiorre, C. J. Med. Chem. 1999, 42, 4214-4224; (d) Guillaumet, G. In Comprehensive Heterocyclic Chemistry II, 1st ed.; Katrizky, A. R.; Rees, C. W.; Scriven, E. F. V., Eds.; Pergamon: Oxford, 1996; Vol. 6, pp. 447-463.
3. For recent reports involving 2,3-dihydro-1,4-benzodioxin derivatives, see: (a) Czompa, A.; Dinya, Z.; Antus, S.; Varga, Z. Arch. Pharm. 2000, 333, 175-180; (b) Gu, W. X.; Jing, X. B.; Pan, X. F.; Chan, A. S. C.; Yang, T. K. Tetrahedron Lett. 2000, 41, 6079-6082; (c) Ward, R. S. Nat. Prod. Rep. 1999, 16, 75-96; (d) Bolognesi, M. L.; Budriesi, R.; Cavalli, A.; Chiarini, A.; Gotti, R.; Leonardi, A.; Minarini, A.; Poggesi, E.; Recanatini, M.; Rosini, M.; Tumiatti, V.; Melchiorre, C. J. Med. Chem. 1999, 42, 4214-4224; (d) Guillaumet, G. In Comprehensive Heterocyclic Chemistry II, 1st ed.; Katrizky, A. R.; Rees, C. W.; Scriven, E. F. V., Eds.; Pergamon: Oxford, 1996; Vol. 6, pp. 447-463.
4. For recent reports involving 2,3-dihydro-1,4-benzodioxin derivatives, see: (a) Czompa, A.; Dinya, Z.; Antus, S.; Varga, Z. Arch. Pharm. 2000, 333, 175-180; (b) Gu, W. X.; Jing, X. B.; Pan, X. F.; Chan, A. S. C.; Yang, T. K. Tetrahedron Lett. 2000, 41, 6079-6082; (c) Ward, R. S. Nat. Prod. Rep. 1999, 16, 75-96; (d) Bolognesi, M. L.; Budriesi, R.; Cavalli, A.; Chiarini, A.; Gotti, R.; Leonardi, A.; Minarini, A.; Poggesi, E.; Recanatini, M.; Rosini, M.; Tumiatti, V.; Melchiorre, C. J. Med. Chem. 1999, 42, 4214-4224; (d) Guillaumet, G. In Comprehensive Heterocyclic Chemistry II, 1st ed.; Katrizky, A. R.; Rees, C. W.; Scriven, E. F. V., Eds.; Pergamon: Oxford, 1996; Vol. 6, pp. 447-463.
5. For recent reports involving 2,3-dihydro-1,4-benzodioxin derivatives, see: (a) Czompa, A.; Dinya, Z.; Antus, S.; Varga, Z. Arch. Pharm. 2000, 333, 175-180; (b) Gu, W. X.; Jing, X. B.; Pan, X. F.; Chan, A. S. C.; Yang, T. K. Tetrahedron Lett. 2000, 41, 6079-6082; (c) Ward, R. S. Nat. Prod. Rep. 1999, 16, 75-96; (d) Bolognesi, M. L.; Budriesi, R.; Cavalli, A.; Chiarini, A.; Gotti, R.; Leonardi, A.; Minarini, A.; Poggesi, E.; Recanatini, M.; Rosini, M.; Tumiatti, V.; Melchiorre, C. J. Med. Chem. 1999, 42, 4214-4224; (d) Guillaumet, G. In Comprehensive Heterocyclic Chemistry II, 1st ed.; Katrizky, A. R.; Rees, C. W.; Scriven, E. F. V., Eds.; Pergamon: Oxford, 1996; Vol. 6, pp. 447-463.
6. Benarab A., Guillaumet G. Heterocycles. 36:1993;2327-2333.
7. Comoy C., Benarab A., Monteil A., Leinot M., Massingham R., Guillaumet G. Med. Chem. Res. 1996;392-399.
8. Sánchez I., Pujol M.D., Guillaumet G., Massingham R., Monteil A., Dureng G., Winslow E. Sci. Pharm. 68:2000;159-164.
9. Soukri M., Lazar S., Akssira M., Guillaumet G. Org. Lett. 2:2000;1557-1560.
10. Benarab A., Commoy C., Guillaumet G. Heterocycles. 38:1994;1641-1650.
11. Matesanz E., Alcázar J., Andrés J.I., Bartolomé J.M., De Bruyn M., Fernández J., Van Emelen K. Tetrahedron Lett. 44:2003;2275-2277.
12. Dieter, A.; Heine, G.; Schohe-Loop, R.; Glaser, T.; De Vry, J. M. V. EP 519291, 1992; Chem. Abstr. 1993, 118, 234051.
13. Arrault A., Touzeau F., Guillaumet G., Léger J.M., Jarrry C., Mérour J.Y. Tetrahedron. 58:2002;8145-8152.
14. When the reaction was tried using NaH in DMF at room temperature or sodium methoxide in MeOH both, at room temperature and under reflux only starting material was recovered unaltered.
15. 2/MeOH (25/1).
16. Longer reaction times afforded mainly decomposition.
17. +: 154.
18. Demerseman P., Kiffer D., Debussche L., Lion C., Royer R., Sentenac-Roumanou H. Eur. J. Med. Chem. 23:1988;63-68.
19. Kleshick W.A., Heathcock C.H. J. Org. Chem. 43:1978;1256-1259.
20. 2/acetone (9/1 and 4/1).
21. +: 166.
22. Benarab A., Poirot P., Guillaumet G. Heterocycles. 36:1993;1589-1599.
23. 2/acetone (9/1), to remove Lawesson's reagent by-products obtained in the course of the reaction and the second one, eluted with hexane/acetone (9/1), to obtain the pure compound.
24. Park M.H., Takeda R., Nakanishi K. Tetrahedron Lett. 28:1987;3823-3824.
25. +: 184.
26. Proudfoot J.R. Biorg. Med. Chem. 5:1995;163-166.
27. 3 or NaH, no reaction took place.
28. +: 181.